KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Accumulated Expenses (2016 - 2024)

Historic Accumulated Expenses for Encompass Health (EHC) over the last 16 years, with Q4 2024 value amounting to $227.9 million.

  • Encompass Health's Accumulated Expenses rose 983.13% to $227.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $227.9 million, marking a year-over-year increase of 983.13%. This contributed to the annual value of $227.9 million for FY2024, which is 983.13% up from last year.
  • As of Q4 2024, Encompass Health's Accumulated Expenses stood at $227.9 million, which was up 983.13% from $207.5 million recorded in Q4 2023.
  • Encompass Health's Accumulated Expenses' 5-year high stood at $253.8 million during Q4 2020, with a 5-year trough of $168.3 million in Q4 2022.
  • In the last 5 years, Encompass Health's Accumulated Expenses had a median value of $207.5 million in 2023 and averaged $211.4 million.
  • In the last 5 years, Encompass Health's Accumulated Expenses tumbled by 2143.42% in 2021 and then surged by 2329.17% in 2023.
  • Over the past 5 years, Encompass Health's Accumulated Expenses (Quarter) stood at $253.8 million in 2020, then dropped by 21.43% to $199.4 million in 2021, then dropped by 15.6% to $168.3 million in 2022, then grew by 23.29% to $207.5 million in 2023, then grew by 9.83% to $227.9 million in 2024.
  • Its last three reported values are $227.9 million in Q4 2024, $207.5 million for Q4 2023, and $168.3 million during Q4 2022.